DRAFT
Note: The following toxicity table is a DRAFT and designed to provide general guidance
on parameters for monitoring safety in clinical trials. This toxicity table is not comprehensive and should not be applied directly to all trials.
When lecting a toxicity table, the following are some of the items that must be taken into consideration:•The population being studied
o Does the clinical trial evaluate healthy subjects, subjects with a particular dia or condition?
回忆往事的句子
•The stage of test article development
o Is the clinical trial a Pha I (is it for the fisrt time in human subjects?) , II, III or IV?
•The type of test article
o Does the clinical trial evaluate a drug, device, vaccine or other biologic agent?
•The prior human and preclinical experience with the test article
o Are there any specific findings that require adjustment of the toxicity table?
o Has it been approved for this indication in adult population?
Single site clinical trials evaluating healthy subjects should conform to the laboratory normal values at the single site. Multi-center clinical trials should reconcile among their laboratory normal values when evaluating a healthy volunteer population.
Plea confer with the DMID protocol team and DMID's Office of Clinical Rearch Affairs when lecting or developing a toxicity table for a DMID-sponsored trial.
DRAFT
ABBREVIATIONS: Abbreviations utilized in the Table:
ULN = Upper Limit of Normal LLN = Lower Limit of Normal
R x = Therapy Req = Required
Mod = Moderate IV = Intravenous
ADL = Activities of Daily Living Dec = Decread
ESTIMATING SEVERITY GRADE
在线沟通
grade of verity:
GRADE 1 Mild Transient or mild discomfort
(< 48 hours); no medical intervention/therapy required
GRADE 2 Moderate Mild to moderate limitation in activity -
闻名中外
some assistance may be needed; no or minimal medical
intervention/therapy required
GRADE 3 Severe Marked limitation in activity, some
assistance usually required; medical intervention/therapy required,
hospitalizations possible
GRADE 4 Life-threatening Extreme limitation in activity, significant
assistance required; significant medical intervention/therapy
required, hospitalization or hospice care probable
GRADE 5 Death
SERIOUS OR LIFE-THREATENING AEs
ANY clinical event deemed by the clinician to be rious or life-threatening should be considered a grade 4 event. Clinical events considered to be rious or life-threatening include, but are not limited to: izures, coma, tetany, diabetic ketoacidosis, disminated intravascular coagulation, diffu petechiae, paralysis, acute psychosis, vere depression.
COMMENTS REGARDING THE USE OF THESE TABLES
• Standardized and commonly ud toxicity tables (Division of AIDS, NCI’s Common Toxicity Criteria (CTC), and World Health Organization (WHO)) have been adapted for u by the Division of Microbiology and Infectious Dias (DMID) and modified to better meet the needs of participants in DMID trials.
• For parameters not included in the following Toxicity Tables, sites should refer to the “Guide For Estimating Severity Grade” located above.
• Criteria are generally grouped by body system.
• Some protocols may have additional protocol specific grading criteria, which will supercede the u of the tables for specified criteria.
DRAFT
(Selected Values for children less than or equal
to 3 months of age – does not apply for preterm infants) For all parameters not listed on this table, plea refer
DRAFT
(Selected Values for children less than or equal
陈皮茯苓茶的功效与作用
to 3 months of age)
消费者行为
西宁市住房公积金黑山村>鲁滨逊漂流记读后感400字DRAFT
(Greater than 3 months of age)
DRAFT
(Greater than 3 months of age)
